{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:48:47Z","timestamp":1782496127021,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaapos.2026.104847","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:27:37Z","timestamp":1777580857000},"page":"104847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative outcomes for treatment of type 1 retinopathy of prematurity in a contemporary cohort"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6017-8722","authenticated-orcid":false,"given":"Anne Strong","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Mehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1189-7319","authenticated-orcid":false,"given":"Jennifer","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2026.104847_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2018.05.024","article-title":"Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: I. Preliminary report","volume":"192","author":"Terry","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ophtha.2023.04.004","article-title":"Causes of childhood blindness in the United States Using the IRIS\u00ae Registry (Intelligent Research in Sight)","volume":"130","author":"Lim","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104847_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41598-021-04616-7","article-title":"Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database","volume":"12","author":"Hong","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaapos.2026.104847_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2006.098582","article-title":"The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years","volume":"90","author":"Good","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","article-title":"Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial","volume":"15","author":"VanderVeen","year":"2011","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104847_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archopht.123.6.825","article-title":"A population-based study on the visual outcome in 10-year-old preterm and full-term children","volume":"123","author":"Larsson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41433-022-02207-y","article-title":"Visual acuity, amblyopia, and vision-related quality of life in preterm adults with and without ROP: results from the Gutenberg prematurity eye study","volume":"37","author":"Fie\u00df","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.jaapos.2026.104847_bib8","first-page":"1408","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function","volume":"108","year":"1990","journal-title":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib9","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jaapos.2026.104847_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaapos.2026.104847_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2026.104847_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2021.11.015","article-title":"Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity","volume":"238","author":"Gundlach","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib13","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41433-023-02559-z","article-title":"Comparison of long-term treatment outcomes of laser and anti-VEGF therapy in retinopathy of prematurity: a multicentre study from J-CREST group","volume":"37","author":"Murakami","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaapos.2026.104847_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaapos.2015.10.017","article-title":"The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm","volume":"20","author":"Cao","year":"2016","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104847_bib15","doi-asserted-by":"crossref","first-page":"354.e1","DOI":"10.1016\/j.ajog.2017.05.029","article-title":"The relationship of the subtypes of preterm birth with retinopathy of prematurity","volume":"217","author":"Lynch","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaapos.2026.104847_bib16","doi-asserted-by":"crossref","first-page":"88.e1","DOI":"10.1016\/j.jaapos.2018.10.013","article-title":"Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP","volume":"23","author":"Anand","year":"2019","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104847_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.10.4.14","article-title":"Longitudinal development of refractive error in children treated with intravitreal bevacizumab or laser for retinopathy of prematurity","volume":"10","author":"Simmons","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jaapos.2026.104847_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","article-title":"Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment","volume":"192","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18240\/ijo.2022.01.16","article-title":"Foveal structure changes in infants treated with anti-VEGF therapy or laser therapy guided by optical coherence tomography angiography for retinopathy of prematurity","volume":"15","author":"Deng","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bjophthalmol-2019-314610","article-title":"Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation","volume":"104","author":"Chen","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaapos.2015.01.009","article-title":"Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser","volume":"19","author":"Isaac","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104847_bib22","first-page":"1556","article-title":"Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurity","volume":"104","author":"Zhao","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib23","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaapos.2026.104847_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102567","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial","volume":"71","author":"Marlow","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaapos.2026.104847_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3341\/kjo.2019.0011","article-title":"Refractive outcomes of 4-year-old children after intravitreal anti-vascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity","volume":"33","author":"Kang","year":"2019","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225643","article-title":"Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: a meta-analysis and systematic review","volume":"14","author":"Tan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2026.104847_bib27","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00417-023-06227-6","article-title":"Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity","volume":"261","author":"Obata","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104847_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/02713683.2016.1196709","article-title":"Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey","volume":"42","author":"Gunay","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jaapos.2026.104847_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279898","article-title":"Association between myopia progression and quantity of laser treatment for retinopathy of prematurity","volume":"17","author":"Hwang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2026.104847_bib30","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","article-title":"Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy","volume":"40","author":"Ling","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2026.104847_bib31","article-title":"Comparison of intravitreal anti-VEGF agents with laser photocoagulation for retinopathy of prematurity of 1,627 eyes in China","volume":"9","author":"Linghu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaapos.2026.104847_bib32","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor","volume":"128","author":"Barry","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:02:22Z","timestamp":1782493342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853126001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1091853126001205"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.104847","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative outcomes for treatment of type 1 retinopathy of prematurity in a contemporary cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.104847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"104847"}}